January 21, 2019
Bristol-Myers Squib deals in its UPSA consumer health business for $1.6 billion
Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myers Squibb’s UPSA consumer health business for $1.6 billion, Bristol-Myers Squibb said in a statement on Saturday.